Podcast brought to you by: Assay Depot - the world's largest cloud-based marketplace for research services. With Assay Depot, you can easily find the perfect research service provider and manage your project from anywhere in the world.
Steve Burrill, CEO, Burrill and Co. Bio and Contact Info
Chapters (Move marker to advance)
0:58 Is there a connection between innovation and austerity?
8:58 Consequences of the world's aging population
13:57 Ramifications of upcoming Supreme Court decision on Affordable Care Act
17:41 Opportunities abroad
25:40 Challenges abroad
31:21 AliveCor and Digital Health
39:03 A biologic on track to be world's top selling drug
Today we’re at the offices of Burrill and Co with CEO, Steve Burrill. Steve hardly needs an introduction in our industry. He was an early pioneer of biotech and helped set up such companies as Genentech and Cetus. Each year Burrill and Co. publishes a book on the state of the industry. It’s a complete almanac of information from what’s going on in such places as Singapore and Brazil to the digital health boom happening right here at home. More importantly it’s not just information, but a comprehensive guide to the industry and full of insight. Steve is more comfortable talking about the future than anyone I know. Today he challenges us with the notion that innovation can come at a time of austerity, and downplays the ramifications of the upcoming Supreme Court decision on the Affordable Care Act of 2010. Burrill also discusses a company he's recently invested in and whose board he chairs, AliveCor and makes his own projections of the rapidly growing industry of digital health.
Support mendelspod.com by purchasing Steve's book, "Innovating in the New Austerity," here.